Clinical Trial: Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade Gliomas

U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07649070) titled 'Phase 2 Trial of G207 + 5 Gy Radiation for Children With High-Grade Gliomas' on June 12.

Brief Summary: The goal of this clinical research study is to learn about the safety and effects of G207 combined with radiation therapy in patients with recurrent or progressive high-grade glioma (HGG).

Study Start Date: Nov. 30, 2026

Study Type: INTERVENTIONAL

Condition: High Grade Gliomas

Intervention: DRUG: G207

Given by injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: M.D. Anderson Cancer Center

Published by HT Digital Content Services with permission from Health Daily Digest....